{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:10:37Z","timestamp":1793887837430,"version":"4.8.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Herein, we report a new modified nanoprecipitation method for the fabrication of water-dispersible Poly(lactic-co-glycolic acid) (PLGA) nanoparticles encapsulating three poorly water-soluble anticancer agents as model drugs: paclitaxel (PTX), docetaxel (DTX) or curcumin (Cur). These nanoparticles were water dispersible with favourable size for anticancer applications (below 200\u00a0nm) and relatively high drug loading (6.3\u20138.9%). These nanoparticles were stable for four weeks in solid state and up to 48\u00a0h when dispersed in water. PTX and Cur nanoparticles showed a very minimal release of the payload during a 72-h <jats:italic>in vitro<\/jats:italic> release study. The new method also yielded reproducible results across three different batches of each type of nanoparticles and following three times upscaling of PTX nanoparticles. PTX and Cur nanoparticles were more effective than the free drugs against MDA-MB-231 cells (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). In addition, PTX nanoparticles showed a significant enhanced induction of early apoptosis in MDA-MB-231 cells (42.3%) in comparison to free PTX (23.7%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Both flow cytometry and confocal microscopy confirmed the uptake of the nanoparticles by MDA-MB-231 cells. In conclusion, our modified nanoprecipitation method produces PLGA nanoparticles loaded with different anticancer agents and suitable for cancer therapy.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1208\/s12248-025-01096-9","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:16:50Z","timestamp":1750965410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Enhanced Nanoprecipitation Method for the Production of PLGA Nanoparticles for\u00a0Oncology Applications"],"prefix":"10.1208","volume":"27","author":[{"given":"Hany Sadek Ayoub","family":"Ghaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naisana","family":"Seyedasli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-9722","authenticated-orcid":false,"given":"Pegah","family":"Varamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"11","key":"1096_CR1","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, Wang S, Chen R, Sun K, et al. Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (London, England). 2021;41(11):1183\u201394. https:\/\/doi.org\/10.1002\/cac2.12207.","journal-title":"Cancer Commun (London, England)"},{"key":"1096_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast (Edinburgh, Scotland). 2022;66:15\u201323. https:\/\/doi.org\/10.1016\/j.breast.2022.08.010.","journal-title":"Breast (Edinburgh, Scotland)"},{"issue":"18","key":"1096_CR3","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1091\/mbc.E14-04-0916","volume":"25","author":"BA Weaver","year":"2014","unstructured":"Weaver BA. How Taxol\/paclitaxel kills cancer cells. Mol Biol Cell. 2014;25(18):2677\u201381. https:\/\/doi.org\/10.1091\/mbc.E14-04-0916.","journal-title":"Mol Biol Cell"},{"issue":"12","key":"1096_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/biom9120789","volume":"9","author":"TM Abu Samaan","year":"2019","unstructured":"Abu Samaan TM, Samec M, Liskova A, Kubatka P, B\u00fcsselberg D. Paclitaxel\u2019s Mechanistic and Clinical Effects on Breast Cancer. Biomol. 2019;9(12):789. https:\/\/doi.org\/10.3390\/biom9120789.","journal-title":"Biomol"},{"issue":"14","key":"1096_CR5","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.phytochem.2006.11.009","volume":"68","author":"DGI Kingston","year":"2007","unstructured":"Kingston DGI. The shape of things to come: structural and synthetic studies of taxol and related compounds. Phytochem. 2007;68(14):1844\u201354. https:\/\/doi.org\/10.1016\/j.phytochem.2006.11.009.","journal-title":"Phytochem"},{"issue":"2","key":"1096_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/ajco.12454","volume":"12","author":"SB Kim","year":"2016","unstructured":"Kim SB, Sayeed A, Villalon AH, Shen ZZ, Shah MA, Hou MF, et al. Docetaxel-based adjuvant therapy for breast cancer patients in Asia-Pacific region: Results from 5 years follow-up on Asia-Pacific Breast Initiative-I. Asia Pac J Clin Oncol. 2016;12(2):125\u201332. https:\/\/doi.org\/10.1111\/ajco.12454.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"16","key":"1096_CR7","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1016\/j.biomaterials.2011.02.022","volume":"32","author":"Y Mi","year":"2011","unstructured":"Mi Y, Liu Y, Feng S-S. Formulation of Docetaxel by folic acid-conjugated d-\u03b1-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomater. 2011;32(16):4058\u201366. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.02.022.","journal-title":"Biomater"},{"issue":"18","key":"1096_CR8","doi-asserted-by":"publisher","first-page":"10648","DOI":"10.1111\/jcmm.15683","volume":"24","author":"X Zhou","year":"2020","unstructured":"Zhou X, Jiao D, Dou M, Zhang W, Lv L, Chen J, et al. Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression. J Cell Mol Med. 2020;24(18):10648\u201362. https:\/\/doi.org\/10.1111\/jcmm.15683.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1096_CR9","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3892\/mmr.2012.1103","volume":"6","author":"XD Sun","year":"2012","unstructured":"Sun XD, Liu XE, Huang DS. Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression. Mol Med Rep. 2012;6(6):1267\u201370. https:\/\/doi.org\/10.3892\/mmr.2012.1103.","journal-title":"Mol Med Rep"},{"issue":"4","key":"1096_CR10","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/adt.2007.064","volume":"5","author":"BT Kurien","year":"2007","unstructured":"Kurien BT, Singh A, Matsumoto H, Scofield RH. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol. 2007;5(4):567\u201376. https:\/\/doi.org\/10.1089\/adt.2007.064.","journal-title":"Assay Drug Dev Technol"},{"issue":"3","key":"1096_CR11","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel). 2011;3(3):1377\u201397. https:\/\/doi.org\/10.3390\/polym3031377.","journal-title":"Polymers (Basel)"},{"key":"1096_CR12","doi-asserted-by":"publisher","first-page":"794601","DOI":"10.1155\/2015\/794601","volume":"2015","author":"E Sah","year":"2015","unstructured":"Sah E, Sah H. Recent Trends in Preparation of Poly(lactide-co-glycolide) Nanoparticles by Mixing Polymeric Organic Solution with Antisolvent. J Nanomater. 2015;2015:794601. https:\/\/doi.org\/10.1155\/2015\/794601.","journal-title":"J Nanomater"},{"issue":"1","key":"1096_CR13","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","volume":"55","author":"H Fessi","year":"1989","unstructured":"Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55(1):R1\u20134. https:\/\/doi.org\/10.1016\/0378-5173(89)90281-0.","journal-title":"Int J Pharm"},{"issue":"1","key":"1096_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","volume":"385","author":"CE Mora-Huertas","year":"2010","unstructured":"Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385(1):113\u201342. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.10.018.","journal-title":"Int J Pharm"},{"issue":"6","key":"1096_CR15","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s11051-012-0876-7","volume":"14","author":"CE Mora-Huertas","year":"2012","unstructured":"Mora-Huertas CE, Couenne F, Fessi H, Elaissari A. Electrokinetic properties of poly-\u03b5-caprolactone-based nanoparticles prepared by nanoprecipitation and emulsification-diffusion methods: a comparative study. J Nanopart Res. 2012;14(6):876. https:\/\/doi.org\/10.1007\/s11051-012-0876-7.","journal-title":"J Nanopart Res"},{"key":"1096_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-319-41421-8_2","volume-title":"Polymer Nanoparticles for Nanomedicines: A Guide for their Design, Preparation and Development","author":"K Miladi","year":"2016","unstructured":"Miladi K, Sfar S, Fessi H, Elaissari A. Nanoprecipitation Process: From Particle Preparation to In Vivo Applications. In: Vauthier C, Ponchel G, editors. Polymer Nanoparticles for Nanomedicines: A Guide for their Design, Preparation and Development. Cham: Springer International Publishing; 2016. p. 17\u201353."},{"issue":"12","key":"1096_CR17","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1002\/anie.201913539","volume":"59","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang G, Baby T, Tengjisi, Chen D, Weitz DA, et al. Stable Polymer Nanoparticles with Exceptionally High Drug Loading by Sequential Nanoprecipitation. Angewandte Chemie Int Ed. 2020;59(12):4720\u20138. https:\/\/doi.org\/10.1002\/anie.201913539.","journal-title":"Angewandte Chemie Int Ed"},{"issue":"2\u20133","key":"1096_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jconrel.2005.08.013","volume":"108","author":"Y Mo","year":"2005","unstructured":"Mo Y, Lim LY. Paclitaxel-loaded PLGA nanoparticles: potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Contr Release: Off J Contr Release Soc. 2005;108(2\u20133):244\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2005.08.013.","journal-title":"J Contr Release: Off J Contr Release Soc"},{"issue":"6","key":"1096_CR19","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","volume":"15","author":"R Paliwal","year":"2014","unstructured":"Paliwal R, Babu RJ, Palakurthi S. Nanomedicine scale-up technologies: feasibilities and challenges. AAPS PharmSciTech. 2014;15(6):1527\u201334. https:\/\/doi.org\/10.1208\/s12249-014-0177-9.","journal-title":"AAPS PharmSciTech"},{"key":"1096_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/B978-0-12-821389-6.00028-5","volume-title":"Biologically Active Peptides","author":"X Sun","year":"2021","unstructured":"Sun X, Okagu OD, Udenigwe CC. Chapter 15 - Encapsulation technology for protection and delivery of bioactive peptides. In: Toldr\u00e1 F, Wu J, editors. Biologically Active Peptides. Academic Press; 2021. p. 331\u201356."},{"issue":"2","key":"1096_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.7314\/APJCP.2014.15.2.517","volume":"15","author":"PLGA-Based Nanoparticles as Cancer Drug Delivery Systems","year":"2014","unstructured":"PLGA-Based Nanoparticles as Cancer Drug Delivery Systems. Asian Pac J Cancer Prev. 2014;15(2):517\u201335.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"1096_CR22","doi-asserted-by":"publisher","first-page":"1000164","DOI":"10.4172\/2157-7439.1000164","volume":"4","author":"P Ma","year":"2013","unstructured":"Ma P, Mumper RJ. Paclitaxel Nano-Delivery Systems: A Comprehensive Review. J Nanomed Nanotechnol. 2013;4(2):1000164. https:\/\/doi.org\/10.4172\/2157-7439.1000164.","journal-title":"J Nanomed Nanotechnol"},{"key":"1096_CR23","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.hsr.2023.100101","volume":"7","author":"N Chaurawal","year":"2023","unstructured":"Chaurawal N, Raza K. Nano-interventions for the drug delivery of docetaxel to cancer cells. Health Sci Rev. 2023;7:100101. https:\/\/doi.org\/10.1016\/j.hsr.2023.100101.","journal-title":"Health Sci Rev"},{"issue":"2","key":"1096_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12248-012-9339-4","volume":"14","author":"N Desai","year":"2012","unstructured":"Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J. 2012;14(2):282\u201395. https:\/\/doi.org\/10.1208\/s12248-012-9339-4.","journal-title":"AAPS J"},{"issue":"1","key":"1096_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41120-022-00060-7","volume":"8","author":"M Alvi","year":"2022","unstructured":"Alvi M, Yaqoob A, Rehman K, Shoaib SM, Akash MSH. PLGA-based nanoparticles for the treatment of cancer: current strategies and perspectives. AAPS Open. 2022;8(1):12. https:\/\/doi.org\/10.1186\/s41120-022-00060-7.","journal-title":"AAPS Open"},{"key":"1096_CR26","doi-asserted-by":"publisher","unstructured":"Debele TA, Yeh CF, Su WP. Cancer Immunotherapy and Application of Nanoparticles in Cancers Immunotherapy as the Delivery of Immunotherapeutic Agents and as the Immunomodulators. Cancers. 2020;12(12). https:\/\/doi.org\/10.3390\/cancers12123773.","DOI":"10.3390\/cancers12123773"},{"key":"1096_CR27","doi-asserted-by":"publisher","unstructured":"Horvath D, Basler M. PLGA Particles in Immunotherapy. Pharm. 2023;15(2). https:\/\/doi.org\/10.3390\/pharmaceutics15020615.","DOI":"10.3390\/pharmaceutics15020615"},{"issue":"2","key":"1096_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0168-3659(02)00212-2","volume":"83","author":"C Fonseca","year":"2002","unstructured":"Fonseca C, Sim\u00f5es S, Gaspar R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Contr Release: Off J Controll Release Soc. 2002;83(2):273\u201386. https:\/\/doi.org\/10.1016\/s0168-3659(02)00212-2.","journal-title":"J Contr Release: Off J Controll Release Soc"},{"issue":"4","key":"1096_CR29","doi-asserted-by":"publisher","first-page":"e0250670","DOI":"10.1371\/journal.pone.0250670","volume":"16","author":"Y Gao","year":"2021","unstructured":"Gao Y, Nai J, Yang Z, Zhang J, Ma S, Zhao Y, et al. A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo. PLoS ONE. 2021;16(4):e0250670. https:\/\/doi.org\/10.1371\/journal.pone.0250670.","journal-title":"PLoS ONE"},{"key":"1096_CR30","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2147\/dddt.S127328","volume":"11","author":"Y Su","year":"2017","unstructured":"Su Y, Hu J, Huang Z, Huang Y, Peng B, Xie N, et al. Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance. Drug Des Dev Ther. 2017;11:659\u201368. https:\/\/doi.org\/10.2147\/dddt.S127328.","journal-title":"Drug Des Dev Ther"},{"issue":"43","key":"1096_CR31","doi-asserted-by":"publisher","first-page":"15344","DOI":"10.1073\/pnas.1411499111","volume":"111","author":"L Tang","year":"2014","unstructured":"Tang L, Yang X, Yin Q, Cai K, Wang H, Chaudhury I, et al. Investigating the optimal size of anticancer nanomedicine. Proc Natl Acad Sci USA. 2014;111(43):15344\u20139. https:\/\/doi.org\/10.1073\/pnas.1411499111.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"1096_CR32","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1023\/b:pham.0000036917.75634.be","volume":"21","author":"S Galindo-Rodriguez","year":"2004","unstructured":"Galindo-Rodriguez S, All\u00e9mann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res. 2004;21(8):1428\u201339. https:\/\/doi.org\/10.1023\/b:pham.0000036917.75634.be.","journal-title":"Pharm Res"},{"key":"1096_CR33","doi-asserted-by":"publisher","first-page":"102027","DOI":"10.1016\/j.jddst.2020.102027","volume":"60","author":"O Esim","year":"2020","unstructured":"Esim O, Bakirhan NK, Sarper M, Savaser A, Ozkan SA, Ozkan Y. Influence of emulsifiers on the formation and in vitro anticancer activity of epirubicin loaded PLGA nanoparticles. J Drug Deliv Sci Technol. 2020;60:102027. https:\/\/doi.org\/10.1016\/j.jddst.2020.102027.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"1096_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0168-3659(02)00025-1","volume":"80","author":"L Mu","year":"2002","unstructured":"Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation\/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol\u00ae). J Control Release. 2002;80(1):129\u201344. https:\/\/doi.org\/10.1016\/S0168-3659(02)00025-1.","journal-title":"J Control Release"},{"issue":"4","key":"1096_CR35","doi-asserted-by":"publisher","first-page":"103987","DOI":"10.1016\/j.jece.2020.103987","volume":"8","author":"D Pinheiro","year":"2020","unstructured":"Pinheiro D, Sunaja Devi KR, Jose A, Rajiv Bharadwaj N, Thomas KJ. Effect of surface charge and other critical parameters on the adsorption of dyes on SLS coated ZnO nanoparticles and optimization using response surface methodology. J Environ Chem Eng. 2020;8(4):103987. https:\/\/doi.org\/10.1016\/j.jece.2020.103987.","journal-title":"J Environ Chem Eng"},{"issue":"2","key":"1096_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.34172\/apb.2021.044","volume":"11","author":"G Mohammadi","year":"2021","unstructured":"Mohammadi G, Fathian-Kolahkaj M, Mohammadi P, Adibkia K, Fattahi A. Preparation, Physicochemical Characterization and Anti-Fungal Evaluation of Amphotericin B-Loaded PLGA-PEG-Galactosamine Nanoparticles. Adv Pharm Bull. 2021;11(2):311\u20137. https:\/\/doi.org\/10.34172\/apb.2021.044.","journal-title":"Adv Pharm Bull"},{"key":"1096_CR37","doi-asserted-by":"publisher","first-page":"126928","DOI":"10.1016\/j.colsurfa.2021.126928","volume":"625","author":"M Beck-Broichsitter","year":"2021","unstructured":"Beck-Broichsitter M. Solvent impact on polymer nanoparticles prepared nanoprecipitation. Colloids Surf, A. 2021;625:126928. https:\/\/doi.org\/10.1016\/j.colsurfa.2021.126928.","journal-title":"Colloids Surf, A"},{"key":"1096_CR38","doi-asserted-by":"publisher","unstructured":"Alkholief M, Kalam MA, Anwer MK, Alshamsan A. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-co-glycolide) Nanoparticles: Encapsulation, In Vitro Release of Indomethacin and Cytotoxicity against HepG2-Cell. Pharm. 2022;14(4). https:\/\/doi.org\/10.3390\/pharmaceutics14040870.","DOI":"10.3390\/pharmaceutics14040870"},{"key":"1096_CR39","doi-asserted-by":"crossref","unstructured":"Sameni J, Bukhari NI, Azlan NA, Julianto T, Majeed ABA. The effect of preparation parameters on the size and morphology of PLGA-based nanoparticles. 2009 IEEE Symp Ind Electron Appl. 2009. p. 700\u20134.","DOI":"10.1109\/ISIEA.2009.5356377"},{"key":"1096_CR40","doi-asserted-by":"publisher","unstructured":"Gatto MS, Najahi-Missaoui W. Lyophilization of Nanoparticles, Does It Really Work? Overview of the Current Status and Challenges. International journal of molecular sciences. 2023;24(18). https:\/\/doi.org\/10.3390\/ijms241814041.","DOI":"10.3390\/ijms241814041"},{"key":"1096_CR41","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2147\/ijn.S121881","volume":"12","author":"P Rafiei","year":"2017","unstructured":"Rafiei P, Haddadi A. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomed. 2017;12:935\u201347. https:\/\/doi.org\/10.2147\/ijn.S121881.","journal-title":"Int J Nanomed"},{"issue":"1","key":"1096_CR42","doi-asserted-by":"publisher","first-page":"23490","DOI":"10.1038\/s41598-021-02503-9","volume":"11","author":"TM Khing","year":"2021","unstructured":"Khing TM, Choi WS, Kim DM, Po WW, Thein W, Shin CY, et al. The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cells. Sci Rep. 2021;11(1):23490. https:\/\/doi.org\/10.1038\/s41598-021-02503-9.","journal-title":"Sci Rep"},{"issue":"2","key":"1096_CR43","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.18632\/aging.102704","volume":"12","author":"Y Chen","year":"2020","unstructured":"Chen Y, Mo L, Wang X, Chen B, Hua Y, Gong L, et al. TPGS-1000 exhibits potent anticancer activity for hepatocellular carcinoma in vitro and in vivo. Aging. 2020;12(2):1624\u201342. https:\/\/doi.org\/10.18632\/aging.102704.","journal-title":"Aging"},{"issue":"6","key":"1096_CR44","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.neuro.2007.04.009","volume":"28","author":"SM Jamieson","year":"2007","unstructured":"Jamieson SM, Liu JJ, Connor B, Dragunow M, McKeage MJ. Nucleolar enlargement, nuclear eccentricity and altered cell body immunostaining characteristics of large-sized sensory neurons following treatment of rats with paclitaxel. Neurotoxicol. 2007;28(6):1092\u20138. https:\/\/doi.org\/10.1016\/j.neuro.2007.04.009.","journal-title":"Neurotoxicol"},{"issue":"9","key":"1096_CR45","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/cplu.202000496","volume":"85","author":"Y Liu","year":"2020","unstructured":"Liu Y, Yang G, Jin S, Xu L, Zhao CX. Development of High-Drug-Loading Nanoparticles. ChemPlusChem. 2020;85(9):2143\u201357. https:\/\/doi.org\/10.1002\/cplu.202000496.","journal-title":"ChemPlusChem"},{"key":"1096_CR46","doi-asserted-by":"publisher","unstructured":"Liu Y, Yang G, Baby T, Tengjisi, Chen D, Weitz D, et al. Stable Polymer Nanoparticles with Exceptionally High Drug Loading by Sequential Nanoprecipitation. Angewandte Chemie. 2020;132. https:\/\/doi.org\/10.1002\/ange.201913539.","DOI":"10.1002\/ange.201913539"},{"key":"1096_CR47","doi-asserted-by":"publisher","first-page":"122985","DOI":"10.1016\/j.ijpharm.2023.122985","volume":"640","author":"NJ Caggiano","year":"2023","unstructured":"Caggiano NJ, Nayagam SK, Wang LZ, Wilson BK, Lewis P, Jahangir S, et al. Sequential Flash NanoPrecipitation for the scalable formulation of stable core-shell nanoparticles with core loadings up to 90%. Int J Pharm. 2023;640:122985. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122985.","journal-title":"Int J Pharm"},{"key":"1096_CR48","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.onano.2022.100036","volume":"6","author":"PS Kumbhar","year":"2022","unstructured":"Kumbhar PS, Nadaf S, Manjappa AS, Jha NK, Shinde SS, Chopade SS, et al. D-\u0251-tocopheryl polyethylene glycol succinate: A review of multifarious applications in nanomedicines. OpenNano. 2022;6:100036. https:\/\/doi.org\/10.1016\/j.onano.2022.100036.","journal-title":"OpenNano"},{"issue":"1","key":"1096_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijpharm.2013.02.004","volume":"446","author":"G Wang","year":"2013","unstructured":"Wang G, Yu B, Wu Y, Huang B, Yuan Y, Liu CS. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel. Int J Pharm. 2013;446(1):24\u201333. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.02.004.","journal-title":"Int J Pharm"},{"issue":"8","key":"1096_CR50","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1177\/0885328215604081","volume":"30","author":"W Shi","year":"2016","unstructured":"Shi W, Yuan Y, Chu M, Zhao S, Song Q, Mu X, et al. Radiosensitization of TPGS-emulsified docetaxel-loaded poly(lactic-co-glycolic acid) nanoparticles in CNE-1 and A549 cells. J Biomater Appl. 2016;30(8):1127\u201341. https:\/\/doi.org\/10.1177\/0885328215604081.","journal-title":"J Biomater Appl"},{"issue":"5","key":"1096_CR51","doi-asserted-by":"publisher","first-page":"479","DOI":"10.4196\/kjpp.2021.25.5.479","volume":"25","author":"P Tran","year":"2021","unstructured":"Tran P, Nguyen TN, Lee Y, Tran PN, Park JS. Docetaxel-loaded PLGA nanoparticles to increase pharmacological sensitivity in MDA-MB-231 and MCF-7 breast cancer cells. Korean J Physiol Pharmacol: Off J Korean Physiol Soc Korean Soc Pharmacol. 2021;25(5):479\u201388. https:\/\/doi.org\/10.4196\/kjpp.2021.25.5.479.","journal-title":"Korean J Physiol Pharmacol: Off J Korean Physiol Soc Korean Soc Pharmacol"},{"key":"1096_CR52","first-page":"43","volume-title":"Ultrasmall Lanthanide Oxide Nanoparticles for Biomedical Imaging and Therapy","author":"GH Lee","year":"2014","unstructured":"Lee GH, Chang Y, Kim T-J. 4 - Characterization. In: Lee GH, Chang Y, Kim T-J, editors. Ultrasmall Lanthanide Oxide Nanoparticles for Biomedical Imaging and Therapy. Woodhead Publishing; 2014. p. 43\u201367."},{"issue":"6","key":"1096_CR53","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S1773-2247(08)50080-3","volume":"18","author":"M Achim","year":"2008","unstructured":"Achim M, Tomuta I, Vlase L, Iuga C, Moldovan M, Leucuta SE. Paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres: preparation and in vitro evaluation. J Drug Deliv Sci Technol. 2008;18(6):410\u20136. https:\/\/doi.org\/10.1016\/S1773-2247(08)50080-3.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"1096_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jconrel.2008.09.086","volume":"133","author":"F Danhier","year":"2009","unstructured":"Danhier F, Lecouturier N, Vroman B, J\u00e9r\u00f4me C, Marchand-Brynaert J, Feron O, et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J Control Release. 2009;133(1):11\u20137. https:\/\/doi.org\/10.1016\/j.jconrel.2008.09.086.","journal-title":"J Control Release"},{"issue":"6","key":"1096_CR55","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/jps.21581","volume":"98","author":"L Mei","year":"2009","unstructured":"Mei L, Sun H, Song C. Local delivery of modified paclitaxel-loaded poly(epsilon-caprolactone)\/pluronic F68 nanoparticles for long-term inhibition of hyperplasia. J Pharm Sci. 2009;98(6):2040\u201350. https:\/\/doi.org\/10.1002\/jps.21581.","journal-title":"J Pharm Sci"},{"issue":"30","key":"1096_CR56","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1039\/c7tb01370a","volume":"5","author":"J Tian","year":"2017","unstructured":"Tian J, Min Y, Rodgers Z, Au KM, Hagan CTt, Zhang M, et al. Co-delivery of paclitaxel and cisplatin with biocompatible PLGA-PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models. J Mater Chem B. 2017;5(30):6049\u201357. https:\/\/doi.org\/10.1039\/c7tb01370a.","journal-title":"J Mater Chem B"},{"issue":"2","key":"1096_CR57","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.actbio.2010.08.029","volume":"7","author":"X Zhang","year":"2011","unstructured":"Zhang X, Zhang X, Wu Z, Gao X, Cheng C, Wang Z, et al. A hydrotropic \u03b2-cyclodextrin grafted hyperbranched polyglycerol co-polymer for hydrophobic drug delivery. Acta Biomater. 2011;7(2):585\u201392. https:\/\/doi.org\/10.1016\/j.actbio.2010.08.029.","journal-title":"Acta Biomater"},{"issue":"10","key":"1096_CR58","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1177\/0885328219837683","volume":"33","author":"J Cai","year":"2019","unstructured":"Cai J, Qian K, Zuo X, Yue W, Bian Y, Yang J, et al. PLGA nanoparticle-based docetaxel\/LY294002 drug delivery system enhances antitumor activities against gastric cancer. J Biomater Appl. 2019;33(10):1394\u2013406. https:\/\/doi.org\/10.1177\/0885328219837683.","journal-title":"J Biomater Appl"},{"issue":"3","key":"1096_CR59","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.bcp.2009.09.003","volume":"79","author":"P Anand","year":"2010","unstructured":"Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol. 2010;79(3):330\u20138. https:\/\/doi.org\/10.1016\/j.bcp.2009.09.003.","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"1096_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10965-020-02092-7","volume":"27","author":"P RS","year":"2020","unstructured":"RS P, Bomb K, Srivastava R, Bandyopadhyaya R. Dual drug delivery of curcumin and niclosamide using PLGA nanoparticles for improved therapeutic effect on breast cancer cells. J Polym Res. 2020;27(5):133. https:\/\/doi.org\/10.1007\/s10965-020-02092-7.","journal-title":"J Polym Res"},{"issue":"12","key":"1096_CR61","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1021\/acs.molpharmaceut.5b00530","volume":"12","author":"J Han","year":"2015","unstructured":"Han J, Michel AR, Lee HS, Kalscheuer S, Wohl A, Hoye TR, et al. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy. Mol Pharm. 2015;12(12):4329\u201335. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5b00530.","journal-title":"Mol Pharm"},{"key":"1096_CR62","doi-asserted-by":"publisher","unstructured":"Weng J, Tong HHY, Chow SF. In Vitro Release Study of the Polymeric Drug Nanoparticles: Development and Validation of a Novel Method. Pharm. 2020;12(8). https:\/\/doi.org\/10.3390\/pharmaceutics12080732.","DOI":"10.3390\/pharmaceutics12080732"},{"issue":"3","key":"1096_CR63","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jconrel.2009.11.002","volume":"142","author":"Z Zhu","year":"2010","unstructured":"Zhu Z, Li Y, Li X, Li R, Jia Z, Liu B, et al. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(\u03b5-caprolactone) nanoparticles: Preparation and antitumor activity in vivo. J Control Release. 2010;142(3):438\u201346. https:\/\/doi.org\/10.1016\/j.jconrel.2009.11.002.","journal-title":"J Control Release"},{"issue":"7","key":"1096_CR64","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/10611860903046628","volume":"17","author":"N Shah","year":"2009","unstructured":"Shah N, Chaudhari K, Dantuluri P, Murthy RSR, Das S. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic\u00aeP85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target. 2009;17(7):533\u201342. https:\/\/doi.org\/10.1080\/10611860903046628.","journal-title":"J Drug Target"},{"issue":"2","key":"1096_CR65","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.colsurfb.2011.06.009","volume":"87","author":"N Song","year":"2011","unstructured":"Song N, Liu W, Tu Q, Liu R, Zhang Y, Wang J. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery. Colloids Surf, B. 2011;87(2):454\u201363. https:\/\/doi.org\/10.1016\/j.colsurfb.2011.06.009.","journal-title":"Colloids Surf, B"},{"issue":"11","key":"1096_CR66","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1023\/B:PHAM.0000003387.15428.42","volume":"20","author":"L Mu","year":"2003","unstructured":"Mu L, Feng S-S. PLGA\/TPGS Nanoparticles for Controlled Release of Paclitaxel: Effects of the Emulsifier and Drug Loading Ratio. Pharm Res. 2003;20(11):1864\u201372. https:\/\/doi.org\/10.1023\/B:PHAM.0000003387.15428.42.","journal-title":"Pharm Res"},{"key":"1096_CR67","doi-asserted-by":"publisher","unstructured":"Zieli\u0144ska A, Carreir\u00f3 F, Oliveira AM, Neves A, Pires B, Venkatesh DN, et al. Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Mol (Basel, Switzerland). 2020;25(16). https:\/\/doi.org\/10.3390\/molecules25163731.","DOI":"10.3390\/molecules25163731"},{"issue":"1","key":"1096_CR68","doi-asserted-by":"publisher","first-page":"2183830","DOI":"10.1080\/10717544.2023.2183830","volume":"30","author":"L Tang","year":"2023","unstructured":"Tang L, Huang K, Jiang W, Fu L, Zhang R, Shen L, et al. Exploration of the inhibition action of TPGS on tumor cells and its combined use with chemotherapy drugs. Drug Deliv. 2023;30(1):2183830. https:\/\/doi.org\/10.1080\/10717544.2023.2183830.","journal-title":"Drug Deliv"},{"key":"1096_CR69","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jddst.2019.01.041","volume":"50","author":"E Bernabeu","year":"2019","unstructured":"Bernabeu E, Gonzalez L, Cagel M, Moretton MA, Chiappetta DA. Deoxycholate-TPGS mixed nanomicelles for encapsulation of methotrexate with enhanced in vitro cytotoxicity on breast cancer cell lines. J Drug Deliv Sci Technol. 2019;50:293\u2013304. https:\/\/doi.org\/10.1016\/j.jddst.2019.01.041.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1096_CR70","doi-asserted-by":"publisher","first-page":"5265","DOI":"10.2147\/ijn.S313166","volume":"16","author":"R Chen","year":"2021","unstructured":"Chen R, Ni S, Chen W, Liu M, Feng J, Hu K. Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles. Int J Nanomed. 2021;16:5265\u201379. https:\/\/doi.org\/10.2147\/ijn.S313166.","journal-title":"Int J Nanomed"},{"issue":"1","key":"1096_CR71","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41598-019-57282-1","volume":"10","author":"J Mann","year":"2020","unstructured":"Mann J, Yang N, Montpetit R, Kirschenman R, Lemieux H, Goping IS. BAD sensitizes breast cancer cells to docetaxel with increased mitotic arrest and necroptosis. Sci Rep. 2020;10(1):355. https:\/\/doi.org\/10.1038\/s41598-019-57282-1.","journal-title":"Sci Rep"},{"key":"1096_CR72","doi-asserted-by":"publisher","first-page":"1153990","DOI":"10.3389\/fimmu.2023.1153990","volume":"14","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Li S, Tang H, Meng X, Zheng Q. Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer. Front Immunol. 2023;14:1153990. https:\/\/doi.org\/10.3389\/fimmu.2023.1153990.","journal-title":"Front Immunol"},{"issue":"2","key":"1096_CR73","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3892\/ijo.2020.5065","volume":"57","author":"F Mohammed","year":"2020","unstructured":"Mohammed F, Rashid-Doubell F, Taha S, Cassidy S, Fredericks S. Effects of curcumin complexes on MDA-MB-231 breast cancer cell proliferation. Int J Oncol. 2020;57(2):445\u201355. https:\/\/doi.org\/10.3892\/ijo.2020.5065.","journal-title":"Int J Oncol"},{"key":"1096_CR74","first-page":"2724","volume":"17","author":"M Mitra","year":"2011","unstructured":"Mitra M, Misra R, Harilal A, Sahoo SK, Krishnakumar S. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells. Mol Vis. 2011;17:2724\u201337.","journal-title":"Mol Vis"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01096-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01096-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01096-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:48:47Z","timestamp":1757198927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01096-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":74,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01096-9","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"ChatGPT-4.0 was used to extract and organise data from eighty fabrication experiments and to\u00a0assist in comparing the results for statistical significance, as reported in the section\u00a0''.\u00a0No other use of AI was made in any part of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"113"}}